346 related articles for article (PubMed ID: 19720167)
1. Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system.
Zhang J; Yan L; Chen W; Lin L; Song X; Yan X; Hang W; Huang B
Anal Chim Acta; 2009 Sep; 650(1):16-22. PubMed ID: 19720167
[TBL] [Abstract][Full Text] [Related]
2. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiles from dried biofluid spots for metabonomic studies using UPLC combined with oaToF-MS.
Michopoulos F; Theodoridis G; Smith CJ; Wilson ID
J Proteome Res; 2010 Jun; 9(6):3328-34. PubMed ID: 20420389
[TBL] [Abstract][Full Text] [Related]
5. Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Zhao YY; Cheng XL; Wei F; Xiao XY; Sun WJ; Zhang Y; Lin RC
Biomarkers; 2012 Feb; 17(1):48-55. PubMed ID: 22133066
[TBL] [Abstract][Full Text] [Related]
6. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Toyo'oka T; Min JZ; Inagaki S; Higashi T; Kagawa Y
J Proteome Res; 2010 Aug; 9(8):3912-22. PubMed ID: 20557141
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy.
Xia JF; Liang QL; Liang XP; Wang YM; Hu P; Li P; Luo GA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1930-6. PubMed ID: 19501555
[TBL] [Abstract][Full Text] [Related]
8. Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry.
Cai X; Zou L; Dong J; Zhao L; Wang Y; Xu Q; Xue X; Zhang X; Liang X
Anal Chim Acta; 2009 Sep; 650(1):10-5. PubMed ID: 19720166
[TBL] [Abstract][Full Text] [Related]
9. The detection of phenotypic differences in the metabolic plasma profile of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry.
Plumb RS; Johnson KA; Rainville P; Shockcor JP; Williams R; Granger JH; Wilson ID
Rapid Commun Mass Spectrom; 2006; 20(19):2800-6. PubMed ID: 16941721
[TBL] [Abstract][Full Text] [Related]
10. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
11. Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: a new tool for lipidomics.
Rainville PD; Stumpf CL; Shockcor JP; Plumb RS; Nicholson JK
J Proteome Res; 2007 Feb; 6(2):552-8. PubMed ID: 17269712
[TBL] [Abstract][Full Text] [Related]
12. Application of ultra performance liquid chromatography-mass spectrometry to profiling rat and dog bile.
Plumb RS; Rainville PD; Potts WB; Johnson KA; Gika E; Wilson ID
J Proteome Res; 2009 May; 8(5):2495-500. PubMed ID: 19253995
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics study on Fuzi and its processed products using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition analysis.
Sun H; Ni B; Zhang A; Wang M; Dong H; Wang X
Analyst; 2012 Jan; 137(1):170-85. PubMed ID: 22030742
[TBL] [Abstract][Full Text] [Related]
14. Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry.
Zhang F; Jia Z; Gao P; Kong H; Li X; Chen J; Yang Q; Yin P; Wang J; Lu X; Li F; Wu Y; Xu G
Talanta; 2009 Aug; 79(3):836-44. PubMed ID: 19576453
[TBL] [Abstract][Full Text] [Related]
15. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride.
Huo T; Cai S; Lu X; Sha Y; Yu M; Li F
J Pharm Biomed Anal; 2009 May; 49(4):976-82. PubMed ID: 19249171
[TBL] [Abstract][Full Text] [Related]
16. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.
Wang C; Kong H; Guan Y; Yang J; Gu J; Yang S; Xu G
Anal Chem; 2005 Jul; 77(13):4108-16. PubMed ID: 15987116
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus.
Li X; Xu Z; Lu X; Yang X; Yin P; Kong H; Yu Y; Xu G
Anal Chim Acta; 2009 Feb; 633(2):257-62. PubMed ID: 19166731
[TBL] [Abstract][Full Text] [Related]
18. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
19. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics.
Gu Y; Zhang Y; Shi X; Li X; Hong J; Chen J; Gu W; Lu X; Xu G; Ning G
Talanta; 2010 May; 81(3):766-72. PubMed ID: 20298851
[TBL] [Abstract][Full Text] [Related]
20. Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry.
Li NJ; Liu WT; Li W; Li SQ; Chen XH; Bi KS; He P
Clin Biochem; 2010 Aug; 43(12):992-7. PubMed ID: 20457143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
